Abbott Laboratories (ABT) Stock Analysis

Catalysts

• ABT is in a pronounced bear market — down ~32% over 12 months, trading well below both the 50-day and 200-day SMAs.
• Momentum is showing signs of stabilizing — the MACD's rapid ascent toward zero and the RSI's recovery from oversold levels are constructive, but neither has confirmed a bullish reversal.
• The stock may be base-building in the $84–$91 range; a decisive break above $91–$92 (the 50-day SMA area) would be a meaningful first step in a potential trend change.

Risks

• Event-driven repricing risk if expectations diverge from incoming evidence.